↑ a et bDewald Schoeman et Burtram C. Fielding, « Is There a Link Between the Pathogenic Human Coronavirus Envelope Protein and Immunopathology? A Review of the Literature », Frontiers in Microbiology, vol. 11, , p. 2086 (PMID33013759, PMCID7496634, DOI10.3389/fmicb.2020.02086)
↑Yipeng Cao, Rui Yang, Imshik Lee, Wenwen Zhang, Jiana Sun, Wei Wang et Xiangfei Meng, « Characterization of the SARS‐CoV ‐2 E Protein: Sequence, Structure, Viroporin, and Inhibitors », Protein Science, vol. 30, no 6, , p. 1114–1130 (PMID33813796, PMCID8138525, DOI10.1002/pro.4075)
↑ a et bVenkata S. Mandala, Matthew J. McKay, Alexander A. Shcherbakov, Aurelio J. Dregni, Antonios Kolocouris et Mei Hong, « Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers », Nature Structural & Molecular Biology, vol. 27, no 12, , p. 1202–1208 (PMID33177698, PMCID7718435, DOI10.1038/s41594-020-00536-8)
↑D. X. Liu, Q. Yuan et Y. Liao, « Coronavirus envelope protein: A small membrane protein with multiple functions », Cellular and Molecular Life Sciences, vol. 64, no 16, , p. 2043–2048 (PMID17530462, PMCID7079843, DOI10.1007/s00018-007-7103-1)